Clinical Trial
Gastrointestinal transit of Sinemet CR in healthy volunteers
Affiliations
- PMID: 2685651
Item in Clipboard
Clinical Trial
Gastrointestinal transit of Sinemet CR in healthy volunteers
Neurology.
1989 Nov.
Abstract
The gastrointestinal transit and systemic absorption of Sinemet CR (50/200) and standard Sinemet (25/100) have been studied in fasting and "fed" healthy human subjects. Both formulations were labeled with a gamma-emitting radionuclide, and their gastric emptying, colon arrival, and in vivo dissolution profiles were monitored using gamma scintigraphy. The standard dosage forms were found to disperse soon after administration and to empty rapidly from both the fasting and the "fed" stomach. The erosion of the controlled-release (CR) system was independent of food. Dosing after a light breakfast altered the gastric emptying profile of the CR formulation and led to significant differences in the plasma levels of levodopa.
Similar articles
-
Pharmacokinetics and bioavailability of Sinemet CR: a summary of human studies.Neurology. 1989 Nov;39(11 Suppl 2):25-38. Neurology. 1989. PMID: 2685649 Clinical Trial.
-
Controlled-release carbidopa/levodopa (Sinemet 50/200 CR4): clinical and pharmacokinetic studies.Neurology. 1989 Nov;39(11 Suppl 2):45-53; discussion 59. Neurology. 1989. PMID: 2685650 Clinical Trial.
-
Pharmaceutical design and development of a Sinemet controlled-release formulation.Neurology. 1989 Nov;39(11 Suppl 2):20-4. Neurology. 1989. PMID: 2685648 Review.
-
Characterisation of the in vivo behaviour of a controlled-release formulation of levodopa (Sinemet CR).Clin Neuropharmacol. 1991 Aug;14(4):305-21. doi: 10.1097/00002826-199108000-00003. Clin Neuropharmacol. 1991. PMID: 1913698 Clinical Trial.
-
Clinical studies with and pharmacokinetic considerations of sustained-release levodopa.Neurology. 1992 Jan;42(1 Suppl 1):29-32; discussion 57-60. Neurology. 1992. PMID: 1549198 Review.
Cited by
-
Defining small differences in efficacy between anti-parkinsonian agents using gait analysis: a comparison of two controlled release formulations of levodopa/decarboxylase inhibitor.Br J Clin Pharmacol. 1993 Apr;35(4):379-85. doi: 10.1111/j.1365-2125.1993.tb04154.x. Br J Clin Pharmacol. 1993. PMID: 8485018 Free PMC article. Clinical Trial.
-
In vivo evaluation of enteric-coated naproxen tablets using gamma scintigraphy.Pharm Res. 1992 Nov;9(11):1436-41. doi: 10.1023/a:1015858829187. Pharm Res. 1992. PMID: 1475230 Clinical Trial.